Online Database of Chemicals from Around the World
Search |  Submit |  中文
Home >> Chemical Listing >> O >> (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 4-oxide

(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 4-oxide
[CAS# 929294-27-9]

List of Suppliers
Shanghai Suifu Chemical Technology Co., Ltd. China Inquire  
+86 (21) 3373-8187
+86 19945655289
suifuchemical@163.com
Skype Chat
QQ chat
Chemical manufacturer since 2017
chemBlink standard supplier since 2019
Complete supplier list of (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 4-oxide
Identification
Name (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 4-oxide
Molecular Structure CAS # 929294-27-9, (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 4-oxide
Molecular Formula C50H65O4P
Molecular Weight 761.02
CAS Registry Number 929294-27-9
Properties
Solubility Insoluble (2.6E-6 g/L) (25 ºC), Calc.*
Density 1.14±0.1 g/cm3 (20 ºC 760 Torr), Calc.*
* Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2019 ACD/Labs)
Safety Data
SDS Available
Market Analysis Reports
List of Reports Available for (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 4-oxide
Related Products
Octahydrodibenz[a,h]anthracene  (5aR,7E,11E,14aS,15S)-rel-5a,6,9,10,13,14,14a,15-Octahydro-1,3-dihydroxy-5a,9,9,12-tetramethyl-15-phenylbenzo[b]cycloundeca[e]pyran-2,4-dicarboxaldehyde  (1R,4S,5S,8R)-rel-1,2,3,4,5,6,7,8-Octahydro-1,4:5,8-dimethanoanthracene-9-carboxaldehyde  3a,4,4a,5,8,8a,9,9a-octahydro-4,9:5,8-Dimethano-1H-benz[f]indene  (11bS)-8,9,10,11,12,13,14,15-Octahydro-N,N-dimethyldinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine  Octahydro-N,N'-dimethyl-4,7-methano-1H-indene-5,?-dimethanamine  (1S,3aR,4S,8aR)-1,2,3,3a,4,5,6,8a-Octahydro-1,4-dimethyl-7-(1-methylethyl)-1,4-azulenediol  Octahydro-4,8a-dimethyl-4a(2H)-naphthalenol  (4aR,5R,7aS,9R)-octahydro-2,2,5,8,8,9a-hexamethyl-4H-4a,9-Methanoazuleno[5,6-d]-1,3-dioxole  (11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 4-oxide  (3R,3aS,3bS,6aS,8aS,9aR)-Octahydro-3-hydroxy-3,8a-dimethyl-6-methylene-1H-oxireno[8,8a]azuleno[4,5-b]furan-5(6H)-one  Octahydro-3'-hydroxy-7',7'a-dimethyl-4-methylenespiro[furan-3(2H),2'-[2H]indene]-2,4'(1'H)-dione  (3aR,4S,7aR)-Octahydro-4-hydroxy-1H-indole-1-carboxylic acid 1,1-dimethylethyl ester  (3S,11E)-3,4,5,6,7,8,9,10-Octahydro-16-hydroxy-3-methyl-1,7-dioxo-1H-2-benzoxacyclotetradecin-14-yl beta-D-glucopyranosiduronic acid  (3aR,4S,7aR)-Octahydro-4-hydroxy-4-[2-(3-methylphenyl)ethynyl]-1H-indole-1-carboxylic acid methyl ester  (3aR,4S,7aR)-Octahydro-4-hydroxy-4-[2-(3-methylphenyl)ethynyl]-1H-indole-1-carboxylic acid tert-butyl ester  (εR,1R,3aR,4S,7aR)-Octahydro-4-hydroxy-α,α,ε,7a-tetramethyl-1H-indene-1-pentanol  (2R,4aR,5R,8aS)-1,2,3,4,4a,5,6,8a-Octahydro-5-hydroxy-alpha,alpha,4a,8-tetramethyl-2-naphthalenemethanol  [1R-[1alpha,(1R*,2E,4S*),3abeta,7aalpha]]-Octahydro-1-(5-hydroxy-1,4,5-trimethyl-2-hexenyl)-7a-methyl-4H-inden-4-one  (1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-Octahydro-1-[(1R,2E,4R)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-1,3-cyclohexanediol